MedTrace Logo

In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System

NCT00803777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2016-02-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the performance and acceptability of a new blood glucose meter.

Conditions

Interventions

DEVICE

Investigational Blood Glucose Monitoring System

Subjects with diabetes used a new blood glucose monitoring system with capillary blood. Certain results were compared to a laboratory glucose method.

Sponsors & Collaborators

  • Ascensia Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Javier Aisenberg, MD · Hackensack Meridian Health

  • Georgeanna Klingensmith, MD · Barbara Davis Center

  • Francine Kaufman, MD · Children's Hospital Los Angeles

  • Timothy Bailey, MD · AMCR Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00803777 on ClinicalTrials.gov